WeightWatchers reported total revenues of $172 million for Q3 2025, a decline of 10.8% year-over-year. Despite a net loss of $58 million, primarily due to a significant income tax charge, the company achieved a robust Adjusted EBITDA of $43 million, reflecting disciplined cost management. Clinical Subscription Revenue showed strong growth of 35.3% year-over-year, and the company's balance sheet was significantly strengthened post-restructuring with total debt reduced by over 70%.
WeightWatchers announced its Q2 2025 results, marked by the successful completion of a strategic reorganization that reduced debt by $1.15 billion. The company reported combined revenues of $189 million, a 6% decrease year-over-year, primarily due to headwinds in the Behavioral business. However, Clinical revenues saw a significant 55% increase, driven by compounded semaglutide subscriptions. Combined End of Period Subscribers declined by 17% year-over-year.
WW International reported a decrease in revenue for Q1 2025 compared to the prior year, primarily due to headwinds in the Behavioral business. However, the Clinical business showed strong growth, and the company significantly improved its Adjusted EBITDAS and Net Loss.
WeightWatchers reported a decrease in total revenues and subscribers for the fourth quarter of fiscal year 2024 compared to the prior year. However, the company achieved significant growth in its Clinical business, with Clinical Subscription Revenues increasing by 57.9% and Clinical Paid Weeks by 53.3%. Profitability metrics such as Gross Margin, Operating Income, and Net Income showed substantial year-over-year improvements, driven by cost management initiatives.
WW International reported a decrease in revenues and subscribers for Q3 2024, with revenues at $192.9 million and a decline in total subscribers to 3.7 million. However, the company saw growth in clinical subscribers and an improvement in gross margin. The company is reiterating its full year fiscal 2024 guidance.
WW International, Inc. reported revenues of $202.1 million and operating income of $35.9 million, with end-of-period subscribers totaling 3.8 million, including 81,000 clinical subscribers.
WW International reported Q1 2024 revenues of $206.5 million. The company's end-of-period subscribers remained steady at 4.0 million, including 91,000 clinical subscribers. The company experienced an operating loss of $269.3 million, primarily due to non-cash intangible impairment charges, but adjusted operating loss was $5.6 million excluding these charges and restructuring costs.
WW International, Inc. reported Q4 2023 results, with revenues of $206.0 million. The company's end-of-period subscribers reached 3.8 million, a 7.1% increase year-over-year. The company returned WeightWatchers to year end subscriber growth – for the first time in 3 years - up 7% year-over-year.
WW International, Inc. reported a 6% year-over-year increase in end-of-period subscribers, reaching 4.0 million. Revenues for Q3 2023 were $214.9 million. The company is updating its full year fiscal 2023 guidance with revenues expected to be at the low end of the previously provided range of $890.0 million to $910.0 million.
WW International, Inc. reported Q2 2023 revenues of $226.8 million and operating income of $26.3 million. The company ended the quarter with 4.1 million subscribers. Sign-ups for WeightWatchers business, excluding Clinical, were up year-over-year.
WW International reported a decrease in revenues to $241.9 million and an operating loss of $28.6 million for Q1 2023. However, the company's CEO expressed confidence in returning to a growth trajectory, citing the acquisition of Sequence and expected improvements in subscriber numbers by the end of the year.
WW International, Inc. reported Q4 2022 revenues of $223.9 million and an operating loss of $50.8 million, primarily due to $57.6 million in non-cash intangible impairment charges. The company ended the year with 3.5 million subscribers, surpassing guidance. WW also announced an agreement to acquire Sequence, a digital health platform for clinical weight management.
WW International reported Q3 2022 revenues of $249.7 million, a gross margin of 61.0%, and an operating loss of $254.5 million, which included $312.7 million in non-cash intangible impairment charges. Adjusted operating income, excluding these charges and restructuring costs, was $61.9 million. The company revised its full-year revenue guidance to approximately $1.04 billion and expects a GAAP diluted net loss per share between ($3.16) and ($3.21).
WW International reported Q2 2022 revenues of $269.5 million, a decrease of 13.5% compared to the prior year. The company's end-of-period subscribers totaled 4.3 million, down 12.3% year-over-year. Despite revenue pressures, adjusted operating income was $58.3 million, reflecting a 10.1% decrease year-over-year, with an adjusted operating margin expansion due to cost management.
WW International reported a decrease in revenue and subscribers for Q3 2021. Revenues were $293.5 million, and end-of-period subscribers were 4.5 million, a 4.3% decrease year-over-year. Despite the revenue decline, the company managed to expand its adjusted operating income margin due to effective cost management.
WW International announced its Q2 2021 results, reporting revenues of $311 million and GAAP EPS of $0.12. The company ended the quarter with 4.9 million subscribers, including 4.1 million digital subscribers. The company is expecting revenue to approach $1.3 billion and GAAP EPS in the range of $1.10 to $1.25 for fiscal year 2021.
WW International, Inc. reported a decrease in revenue but an increase in digital subscribers for Q1 2021. The company ended the quarter with 5.0 million subscribers, including a record 4.2 million digital subscribers. Revenue was $332 million, and the gross margin was 58%.
WW International, Inc. announced Q4 2020 results with revenues of $323.4 million, a decrease of 3% year-over-year. The company saw growth in digital subscribers, up 24% year-over-year, and an increase in adjusted gross margin to over 61%.
WW International, Inc. announced its Q3 2020 results, showing subscriber growth and matched operating income levels despite COVID-19 impacts. The company ended the quarter with 4.7 million subscribers, marking a new record for a third quarter close. The power of high-margin digital subscription business is demonstrated in the Q3 results as year-over-year the company grew total subscribers, matched operating income levels, and grew EPS.
WW International reported a decrease in revenue by 10% year-over-year to $334 million, but digital subscribers reached an all-time high, up 23% year-over-year. Adjusted EPS was $0.67, demonstrating strong performance despite the COVID-19 environment.
WW International, Inc. announced Q1 2020 results with revenues of $400.4 million, up 10% year-over-year. The company reported a net loss of $6.1 million, but end-of-period subscribers increased by 9% to 5.0 million. The company withdrew its full year fiscal 2020 guidance due to COVID-19 uncertainty.
WW International, Inc. reported Q4 2019 revenues of $333 million and EPS of $0.42. The company's end-of-period subscribers reached 4.2 million, an 8% increase year-over-year.